Sumitomo Pharma Co., Ltd. (TYO:4506)

Japan flag Japan · Delayed Price · Currency is JPY
1,593.00
-57.00 (-3.45%)
Sep 26, 2025, 3:30 PM JST
161.58%
Market Cap 632.88B
Revenue (ttm) 416.16B
Net Income (ttm) 18.90B
Shares Out 397.29M
EPS (ttm) 47.58
PE Ratio 33.48
Forward PE 9.42
Dividend n/a
Ex-Dividend Date n/a
Volume 6,572,600
Average Volume 6,961,305
Open 1,630.00
Previous Close 1,650.00
Day's Range 1,560.00 - 1,632.00
52-Week Range 496.00 - 1,840.00
Beta 0.55
RSI 51.62
Earnings Date Oct 31, 2025

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. engages in manufacture, purchase, and sale of pharmaceutical products for medical treatment in Japan, North America, and Asia. The company offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. It also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, the company offers veterinary drugs, medical devices, etc. It h... [Read more]

Sector Healthcare
Founded 1897
Employees 3,832
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4506
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.